Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results

Go back to Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 2.75 -0.03 (1.08%)
Previous Close $2.78    52 Week High $ 
Open $2.77    52 Week Low $ 
Day High $2.84    P/E N/A 
Day Low $2.72    EPS $ 
Volume 717,993